Viatris Inc (FRA:VIA)
€ 11.935 -0.44 (-3.56%) Market Cap: 14.33 Bil Enterprise Value: 27.28 Bil PE Ratio: 0 PB Ratio: 0.81 GF Score: 66/100

Viatris Inc at JPMorgan Healthcare Conference (Virtual) Transcript

Jan 14, 2021 / 12:30PM GMT
Release Date Price: €14.5 (-5.23%)
Christopher Thomas Schott
JPMorgan Chase & Co, Research Division - Senior Analyst

Good morning. I'm Chris Schott at JPMorgan. I'm very pleased to be introducing the newly formed Viatris for the company's first official presentation at the JPMorgan Healthcare Conference. We're going to have a presentation from the company's CEO, Michael Goettler, and then we're going to open up to a Q&A session with the broader management team from there. (Operator Instructions)

And with that, let me turn it over to Michael.

Michael Goettler
Viatris Inc. - CEO & Executive Director

All right. Good morning, Chris. Very nice to be back at JPMorgan, even though in a virtual format, and thanks for hosting us. And to the audience, I want to say thank you for joining us so early in the morning, East Coast time, 7 a.m., but for our first JPMorgan presentation as Viatris. A new kind of health care company that really came into being only 2 months ago.

What I would like to share with you today are really 3 topics. Number one, who is Viatris and give you a

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot